Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO, Howell RM, Wolden SL, Constine LS, Diller LR, Sklar CA, Nathan PC, Castellino SM, Barnea D, Smith SA, Hutchinson RJ, Armstrong GT, Robison LL.
Oeffinger KC, et al. Among authors: hudson mm.
J Clin Oncol. 2021 Jul 10;39(20):2266-2275. doi: 10.1200/JCO.20.01186. Epub 2021 Feb 25.
J Clin Oncol. 2021.
PMID: 33630659
Free PMC article.